Alyeska Investment Group’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,508
Closed -$346K 697
2021
Q1
$346K Sell
3,508
-2,000
-36% -$197K ﹤0.01% 677
2020
Q4
$597K Sell
5,508
-44
-0.8% -$4.77K 0.01% 435
2020
Q3
$572K Buy
+5,552
New +$572K 0.01% 410
2018
Q2
Sell
-9,100
Closed -$528K 407
2018
Q1
$528K Buy
+9,100
New +$528K ﹤0.01% 380